Total Funding
75
50
Total FundingPost-IPO Debt raised
Growth Score
-8 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
130892
Tissue Regenix commercializes innovative technologies in regenerative medicine.
Eileen Ingham: Co-Founder- John Fisher: Co-Founder
About the Company
Tissue Regenix commercializes innovative technologies in regenerative medicine. The underpinning science was developed over the last decade in the world-leading Institute for Medical and Biological Engineering at the University of Leeds by Professors John Fisher and Eileen Ingham.
Tissue Regenix was founded in May 2006, to commercialize innovative
technologies in regenerative medicine.
